Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Johnson & Johnson
Johnson & Johnson
Page 12 of 18
Newsletters
Earnings season is here. Will companies deliver on the hype?
By
Bernhard Warner
October 13, 2020
Health
J&J pauses COVID-19 vaccine trial after participant falls ill
By
Bloomberg
October 13, 2020
Health
Which COVID-19 vaccine works best? A new lab network promises an answer
By
Jeremy Kahn
October 6, 2020
Conferences
How 3 of biopharma’s most powerful women are building public trust during COVID
By
Sy Mukherjee
September 29, 2020
Health
Under fire, AstraZeneca CEO defends transparency of COVID-19 vaccine trials
By
Jeremy Kahn
September 24, 2020
Health
Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing
By
Jay Hancock, Kaiser Health News
August 24, 2020
Tech
Johnson & Johnson just invested in a telemedicine startup. Here’s why
By
Jonathan Vanian
August 14, 2020
Health
Johnson & Johnson antidepressant spray approved for treating those at risk of suicide
By
Cynthia Koons
and
Bloomberg
August 3, 2020
Newsletters
Johnson & Johnson’s CEO on building trust for a coronavirus vaccine
By
Sy Mukherjee
July 9, 2020
Newsletters
J&J’s CEO says creating a vaccine is only ‘part of the puzzle’
By
Katherine Dunn
and
Alan Murray
July 9, 2020
Health
5 companies to keep an eye on following the world’s largest cancer conference
By
Sy Mukherjee
June 3, 2020
Newsletters
Big pharma’s big chance
By
Katherine Dunn
and
Alan Murray
April 3, 2020
Newsletters
Johnson & Johnson CEO on the race to make a coronavirus vaccine
By
Katherine Dunn
and
Alan Murray
March 31, 2020
Newsletters
J&J’s coronavirus vaccine could hit the market by 2021
By
Sy Mukherjee
March 30, 2020
Health
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
By
Sy Mukherjee
March 30, 2020
Most Popular
Economy
3 things Trump did in 24 hours to show that he's in control of American business
By
Eva Roytburg
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do...
By
Nick Lichtenberg
Economy
Making billionaires illegal by taxing their wealth wouldn’t even fund the government for a year, budget expert says
By
Nick Lichtenberg